Correlation Between Milestone Pharmaceuticals and Connect Biopharma
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Connect Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Connect Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Connect Biopharma Holdings, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Connect Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Connect Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Connect Biopharma.
Diversification Opportunities for Milestone Pharmaceuticals and Connect Biopharma
-0.67 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Milestone and Connect is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Connect Biopharma Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Connect Biopharma and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Connect Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Connect Biopharma has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Connect Biopharma go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Connect Biopharma
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 0.91 times more return on investment than Connect Biopharma. However, Milestone Pharmaceuticals is 1.1 times less risky than Connect Biopharma. It trades about 0.36 of its potential returns per unit of risk. Connect Biopharma Holdings is currently generating about -0.06 per unit of risk. If you would invest 145.00 in Milestone Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of 54.00 from holding Milestone Pharmaceuticals or generate 37.24% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Connect Biopharma Holdings
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Connect Biopharma |
Milestone Pharmaceuticals and Connect Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Connect Biopharma
The main advantage of trading using opposite Milestone Pharmaceuticals and Connect Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Connect Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Connect Biopharma will offset losses from the drop in Connect Biopharma's long position.The idea behind Milestone Pharmaceuticals and Connect Biopharma Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Connect Biopharma vs. Assembly Biosciences | Connect Biopharma vs. Instil Bio | Connect Biopharma vs. CytomX Therapeutics | Connect Biopharma vs. Achilles Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |